Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (1-10 of 293) with videos related to

Pageof 30
Sort By:
Seminars in Oncology|July 30, 1999
Doxorubicin/taxane combinations: cardiac toxicity and pharmacokineticsJ A Sparano
Seminars in Oncology|April 13, 2001
Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trialsJ A Sparano
Current Opinion in Oncology|September 1, 2007
HIV-associated lymphoma: the evidence for treating aggressively but with cautionJoseph A Sparano
Current Opinion in Oncology|September 1, 1995
Treatment of AIDS-related lymphomasJ A Sparano
Seminars in Oncology|October 13, 1998
Use of dexrazoxane and other strategies to prevent cardiomyopathy associated with doxorubicin-taxane combinationsJ A Sparano
Current Opinion in Oncology|September 10, 2003
Human immunodeficiency virus associated lymphomaJoseph A Sparano
Seminars in Oncology|December 29, 1998
Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignanciesJ A Sparano
European Journal of Cancer (Oxford, England : 1990)|June 26, 2001
Clinical aspects and management of AIDS-related lymphomaJ A Sparano
Clinical Breast Cancer|March 20, 2002
Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trialsJ A Sparano
Current Opinion in Oncology|September 1, 1996
Infection prophylaxis and antiretroviral therapy in patients with HIV infection and malignancyJ A Sparano, C Sarta
Pageof 30

Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Seminars in Oncology|July 30, 1999
Doxorubicin/taxane combinations: cardiac toxicity and pharmacokineticsJ A Sparano
Seminars in Oncology|April 13, 2001
Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trialsJ A Sparano
Current Opinion in Oncology|September 1, 2007
HIV-associated lymphoma: the evidence for treating aggressively but with cautionJoseph A Sparano
Current Opinion in Oncology|September 1, 1995
Treatment of AIDS-related lymphomasJ A Sparano
Seminars in Oncology|October 13, 1998
Use of dexrazoxane and other strategies to prevent cardiomyopathy associated with doxorubicin-taxane combinationsJ A Sparano
Current Opinion in Oncology|September 10, 2003
Human immunodeficiency virus associated lymphomaJoseph A Sparano
Seminars in Oncology|December 29, 1998
Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignanciesJ A Sparano
European Journal of Cancer (Oxford, England : 1990)|June 26, 2001
Clinical aspects and management of AIDS-related lymphomaJ A Sparano
Clinical Breast Cancer|March 20, 2002
Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trialsJ A Sparano
Current Opinion in Oncology|September 1, 1996
Infection prophylaxis and antiretroviral therapy in patients with HIV infection and malignancyJ A Sparano, C Sarta
Pageof 30